fig2

Figure 2. Causative involvement of GSK3β in upfront sarcoma therapies and in the adverse events associated with therapy. →: promoting; —|: suppressive; dotted line: hypothetical effect; NKT: natural killer T; MSCs, mesenchymal stem cells; CAR: chimeric antigen receptor; CNS: central nervous system; GSK3β: glycogen synthase kinase 3β